Literature DB >> 19719782

The signal transduction cascade regulating the expression of the gap junction protein connexin43 by beta-adrenoceptors.

A Salameh1, S Krautblatter, S Karl, K Blanke, D Rojas Gomez, S Dhein, D Pfeiffer, J Janousek.   

Abstract

BACKGROUND AND
PURPOSE: In mammalian heart, connexin43 (Cx43) represents the predominant connexin in the working myocardium. As the beta-adrenoceptor is involved in many cardiac diseases, we wanted to clarify the pathway by which beta-adrenoceptor stimulation may control Cx43 expression. EXPERIMENTAL APPROACH: Cultured neonatal rat cardiomyocytes were stimulated with isoprenaline. Cx43 expression as well as activation of p38 mitogen-activated protein kinase (MAPK), p42/44 MAPK, JUN NH(2)-terminal kinase (JNK) and nuclear translocation of the transcription factors activator protein 1 (AP1) and CRE-binding protein (CREB) were investigated. Additionally, we assessed Cx43 expression and distribution in left ventricular biopsies from patients without any significant heart disease, and from patients with either congestive heart failure [dilated cardiomyopathy (DCM)] or hypertrophic cardiomyopathy (HCM). KEY
RESULTS: Isoprenaline exposure caused about twofold up-regulation of Cx43 protein with a pEC(50) of 7.92 +/- 0.11, which was inhibited by propranolol, SB203580 (4-(4-fluorophenyl)-2-(4-methylsulphinylphenyl)-5-(4-pyridyl)-1H-imidazole) (p38 inhibitor), PD98059 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one) (MAPK 1 kinase inhibitor) (Alexis Biochemicals, San Diego, CA, USA) or cyclosporin A. Similar findings were obtained for Cx43 mRNA. Furthermore, Cx43 up-regulation was accompanied by phosphorylation of p38, p42/44 and JNK, and by translocation of AP1 and CREB to the nucleus. Analysis of Cx43 protein and mRNA in ventricular biopsies revealed that in patients with DCM, Cx43 content was significantly lower, and in patients with HCM, Cx43 content was significantly higher, relative to patients without any cardiomyopathy. More importantly, Cx43 distribution also changed with more Cx43 being localized at the lateral border of the cardiomyocytes. CONCLUSION AND IMPLICATION: Beta-adrenoceptor stimulation up-regulated cardiac Cx43 expression via a protein kinase A and MAPK-regulated pathway, possibly involving AP1 and CREB. Cardiomyopathy altered Cx43 expression and distribution.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19719782      PMCID: PMC2795252          DOI: 10.1111/j.1476-5381.2009.00344.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Increased JNK, AP-1 and NF-kappa B DNA binding activities in isoproterenol-induced cardiac remodeling.

Authors:  Y Takemoto; M Yoshiyama; K Takeuchi; T Omura; R Komatsu; Y Izumi; S Kim; J Yoshikawa
Journal:  J Mol Cell Cardiol       Date:  1999-11       Impact factor: 5.000

3.  Beta-adrenoceptor stimulation attenuates the hypertrophic effect of alpha-adrenoceptor stimulation in adult rat ventricular cardiomyocytes.

Authors:  M Schäfer; K Pönicke; I Heinroth-Hoffmann; O E Brodde; H M Piper; K D Schlüter
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

4.  Differential effects of bucindolol and carvedilol on noradenaline-induced hypertrophic response in ventricular cardiomyocytes of adult rats.

Authors:  Klaus Pönicke; Ingrid Heinroth-Hoffmann; Otto-Erich Brodde
Journal:  J Pharmacol Exp Ther       Date:  2002-04       Impact factor: 4.030

5.  Gq/11-coupled receptors and protein synthesis in rat cardiomyocytes: role of Gi-proteins and protein kinase C-isozymes.

Authors:  K Pönicke; I Heinroth-Hoffmann; K Becker; B Osten; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1999-09       Impact factor: 3.000

6.  Altered connexin expression in human congestive heart failure.

Authors:  E Dupont; T Matsushita; R A Kaba; C Vozzi; S R Coppen; N Khan; R Kaprielian; M H Yacoub; N J Severs
Journal:  J Mol Cell Cardiol       Date:  2001-02       Impact factor: 5.000

7.  Activation and inactivation of cAMP-response element-mediated gene transcription in cardiac myocytes.

Authors:  F U Müller; P Bokník; J Knapp; B Linck; H Lüss; J Neumann; W Schmitz
Journal:  Cardiovasc Res       Date:  2001-10       Impact factor: 10.787

8.  Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria.

Authors:  L Polontchouk; J A Haefliger; B Ebelt; T Schaefer; D Stuhlmann; U Mehlhorn; F Kuhn-Regnier; E R De Vivie; S Dhein
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

9.  beta 2-adrenergic receptor-induced p38 MAPK activation is mediated by protein kinase A rather than by Gi or gbeta gamma in adult mouse cardiomyocytes.

Authors:  M Zheng; S J Zhang; W Z Zhu; B Ziman; B K Kobilka; R P Xiao
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

10.  Enhanced transmural fiber rotation and connexin 43 heterogeneity are associated with an increased upper limit of vulnerability in a transgenic rabbit model of human hypertrophic cardiomyopathy.

Authors:  Crystal M Ripplinger; Wenwen Li; Jennifer Hadley; Junjie Chen; Florence Rothenberg; Raffaella Lombardi; Samuel A Wickline; Ali J Marian; Igor R Efimov
Journal:  Circ Res       Date:  2007-09-20       Impact factor: 17.367

View more
  27 in total

1.  A simulation study of cellular hypertrophy and connexin lateralization in cardiac tissue.

Authors:  Thomas Seidel; Aida Salameh; Stefan Dhein
Journal:  Biophys J       Date:  2010-11-03       Impact factor: 4.033

2.  GPCR theme editorial.

Authors:  G Milligan; J C McGrath
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

3.  Synergistic effects of AKAP95, Cyclin D1, Cyclin E1, and Cx43 in the development of rectal cancer.

Authors:  Fengjie Qi; Yangyang Yuan; Xuehong Zhi; Qian Huang; Yuexin Chen; Wenxin Zhuang; Dengcheng Zhang; Bogang Teng; Xiangyu Kong; Yongxing Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  Dipyridamole-related enhancement of gap junction coupling in the GM-7373 aortic endothelial cells correlates with an increase in the amount of connexin 43 mRNA and protein as well as gap junction plaques.

Authors:  Daniela Begandt; Almke Bader; Linda Gerhard; Julia Lindner; Lutz Dreyer; Barbara Schlingmann; Anaclet Ngezahayo
Journal:  J Bioenerg Biomembr       Date:  2013-06-26       Impact factor: 2.945

5.  CELF1 regulates gap junction integrity contributing to dilated cardiomyopathy.

Authors:  Danielle A Jeffrey; Carmen C Sucharov
Journal:  Noncoding RNA Investig       Date:  2018-03-07

6.  Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.

Authors:  Ali J Marian; Babken Asatryan; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

7.  Optimizing a spontaneously contracting heart tissue patch with rat neonatal cardiac cells on fibrin gel.

Authors:  Ze-Wei Tao; Mohamed Mohamed; Matthew Hogan; Laura Gutierrez; Ravi K Birla
Journal:  J Tissue Eng Regen Med       Date:  2014-04-28       Impact factor: 3.963

8.  Cardiac fibroblasts inhibit β-adrenoceptor-dependent connexin43 expression in neonatal rat cardiomyocytes.

Authors:  A Salameh; H Djilali; K Blanke; J Gonzalez Casanova; S von Salisch; A Savtschenko; S Dhein; I Dähnert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-03-03       Impact factor: 3.000

Review 9.  Stimulation of cardiac beta-adrenoceptors targets connexin 43.

Authors:  Kerstin Boengler
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

10.  On the different roles of AT1 and AT2 receptors in stretch-induced changes of connexin43 expression and localisation.

Authors:  Aida Salameh; Daniel Apel; Jorge Gonzalez Casanova; Sandy von Salisch; Friedrich-Wilhelm Mohr; Ingo Daehnert; Stefan Dhein
Journal:  Pflugers Arch       Date:  2012-09-25       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.